Hemostasis Today

October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Micheal Avoseh: Exploring Nanoparticle-Based Therapies for Thrombosis and Vascular Inflammation
Oct 9, 2026, 23:38

Micheal Avoseh: Exploring Nanoparticle-Based Therapies for Thrombosis and Vascular Inflammation

Micheal Avoseh, Doctoral Researcher at University of South Carolina Floyd School of Medicine, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in blood VTH, adding:

“I’m excited to share that our article, Endothelium-Targeted and Untargeted Nanoparticle Therapies in Thrombo-Inflammatory Vascular Diseases, is now published in blood VTH.

This review explores how nanoparticle-based therapies may help address thrombo-inflammatory vascular disease, including approaches that target the endothelium—the inner lining of blood vessels—and approaches that do not.

It was a valuable opportunity to examine how drug delivery strategies could improve the way we approach complex vascular inflammation and thrombosis.

I’m grateful to my co-authors and mentors for their collaboration and guidance throughout this work.”

Title: Endothelium-Targeted and Untargeted Nanoparticle Therapies in Thrombo-Inflammatory Vascular Diseases

Authors: Micheal O. Avoseh, Hua Jin, Oscar Moreno, Andrea T. Obi, Peter K. Henke, Souvik Sen, Michael A. Matthay, You-Yang Zhao, Colin E. Evans

Micheal Avoseh

Stay updated on all scientific advances with Hemostasis Today.